Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Encompass Health Q3 2026 Results: Net Income $150M, Up 18.5% YoY

Encompass Health reported net operating revenues of $1,609.5 million for the third quarter of 2026, a 9% increase over the prior year. Net income attributable to the company rose to $149.9 million, driven by strong performance in continuing operations despite increased operating expenses and share repurchases totaling $204.2 million for the nine-month period.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue1,609.51,477.5
Profit before tax257.8219.9
Net income149.9126.5
EPS (diluted, $ a share)$1.50$1.24

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+18.5%
Revenue, year on year+8.9%
Source

10-Q filed with the SEC, NYSE: EHC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Encompass Health Corp: key numbers

Share price
$137.88Close, Nov 17
Market cap
$13.5B
Shares outstanding
98.12MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-HospitalsSIC 8060

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Encompass Health Corp

All →
7:36 AM ET 8-K
Business Update

Encompass Health Business Update

Encompass Health announced the indefinite closure of its 90-bed Sea Pines Rehabilitation Hospital in Melbourne, Florida, following catastrophic flooding and patient evacuation on November 1-2, 2026. The company is evaluating options to refurbish or replace the facility with its joint venture partner, Holmes Regional Medical Center. Despite the closure, the company reaffirmed its full-year 2026 financial guidance.

4:26 PM ET 8-K
Financial Results

Encompass Health Financial Results

Encompass Health reported Q3 2026 net operating revenue of $1.61 billion, an 8.9% increase year-over-year, driven by a 5.7% growth in discharges. The company increased its full-year 2026 guidance for revenue, Adjusted EBITDA, and adjusted EPS following strong performance and the opening of four new hospitals year-to-date.

Term
Q3 2026

“We are very pleased with our performance for the third quarter, with revenue increasing 8.9% and Adjusted EBITDA growing 15.5%. During the first nine months of 2026, we opened four hospitals totaling 189 beds and added 85 beds to existing hospitals, reflecting our commitment to meeting the growing demand for high-quality inpatient rehabilitation services. Our value proposition and disciplined operating strategy continue to be validated, and we remain highly optimistic about the long-term prospects of our business.”

Mark Tarr, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.